At Jabi TDD Solutions, we are on the brink of revolutionizing the pharmaceutical industry in Canada. Our cutting-edge precise drug fabrication and delivery system, powered by 3D printing technology, is set to redefine how medicines are produced and delivered. By using the Semi-Solid Extrusion technique with Alginate and Corn Starch as ink, we can create customized tablets with tailored dosages, physical appearance, and release characteristics, all while ensuring safer and more effective health outcomes for patients.

Our technology is not just innovative—it’s transformative. Traditional manufacturing methods often result in long production times and significant material waste. In contrast, our 3D printing system offers a versatile, layered manufacturing process that significantly reduces both production time and material wastage. This efficiency allows us to produce small batches of tablets quickly and cost-effectively, addressing the industry’s need for on-demand drug production and minimizing shortages.

One of the most exciting aspects of our technology is its ability to create customized polypills. These tablets can carry multiple drugs in a single dose, with each component tailored for specific release properties, shape, size, and carrying capacity. This capability is a game-changer for personalized medicine, enabling healthcare providers to offer treatments that are precisely aligned with individual patient needs.

The implications of our technology for the Canadian pharmaceutical market are profound. By optimizing the printing and material parameters in our 3D printers, we have developed a system that can produce tablets with maximum drug loading, ideal mechanical characteristics, and controlled drug release behavior. This not only enhances patient compliance but also opens new frontiers in pharmaceutical research, moving beyond conventional business approaches.

Our system will empower medical professionals across Canada to produce medicines in small batches, directly at clinics, hospitals, and pharmacies. This means that personalized, on-demand drug production is no longer a distant possibility but a present reality. With Jabi TDD Solutions, the pharmaceutical industry in Canada is poised for a new era of innovation, where high structural complexity, customer-specific designs, and reduced material costs become the norm.

The benefits of our 3D printing technology are clear:

• Small batch production with tailored dosages and release characteristics
• Customized physical appearance and flavor of pharmaceuticals
• On-demand drug production at point-of-care facilities
• Enhanced patient compliance, leading to safer and more effective treatments

As we look to the future, Jabi TDD Solutions is committed to driving the pharmaceutical industry forward, ensuring that every patient in Canada has access to the most advanced, personalized treatments available. Our technology is not just a step forward; it’s a leap into a new era of medicine.